Availability and legality vary by state, and the situation continues to evolve
[29] highlighted weight loss ranging from 5 to 17% with arGLP-1 in similar contexts, emphasizing the efficacy of this class of drugs in mitigating insufficient surgical outcomes
I want to touch base really quickly on something you said earlier regarding food as pleasure and the joy of eating
The net effect is still overwhelmingly positive for most people, but it is worth being aware of
Tirzepatide for maintenance of bodyweight reduction in people with obesity in the USA (SURMOUNT-MAINTAIN): a multicentre, double-blind, randomised, placebo-controlled trial, Lancet (2026) [PubMed abstract] Tirzepatide (Zepbound) review
GLP-1 (short for glucagon-like peptide 1) is basically insulins boss